Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Heparin and cancer.

Literature DB >> 9684778

Heparin and cancer.

L R Zacharski¹, D L Ornstein.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1998 PMID： 9684778

Source DB: PubMed Journal: Thromb Haemost ISSN： 0340-6245 Impact factor: 5.249

Keyword Cloud
Cited

× No keyword cloud information.

20 in total

1. Six blind men and the elephant--the many faces of heparan sulfate.

Authors: Ajit Varki
Journal: Proc Natl Acad Sci U S A Date: 2002-01-22 Impact factor: 11.205

2. In vivo treatment of rats with unfractionated heparin (UFH) or low molecular weight heparin (LMWH) does not affect experimentally induced colon carcinoma metastasis.

Authors: S M Smorenburg; R Vink; M te Lintelo; W Tigchelaar; A Maas; H R Büller; C J van Noorden
Journal: Clin Exp Metastasis Date: 1999-07 Impact factor: 5.150

3. Heparin blocks transfer of extracellular vesicles between donor and recipient cells.

Authors: Nadia A Atai; Leonora Balaj; Henk van Veen; Xandra O Breakefield; Peter A Jarzyna; Cornelis J F Van Noorden; Johan Skog; Casey A Maguire
Journal: J Neurooncol Date: 2013-09-04 Impact factor: 4.130

Review 4. Duration of anticoagulation for venous thromboembolism.

Authors: C Kearon
Journal: J Thromb Thrombolysis Date: 2001-09 Impact factor: 2.300

5. Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis.

Authors: L Borsig; R Wong; J Feramisco; D R Nadeau; N M Varki; A Varki
Journal: Proc Natl Acad Sci U S A Date: 2001-03-13 Impact factor: 11.205

10. FRAGMATIC: a randomised phase III clinical trial investigating the effect of fragmin added to standard therapy in patients with lung cancer.

Authors: Gareth O Griffiths; Sarah Burns; Simon I Noble; Fergus R Macbeth; David Cohen; Timothy S Maughan
Journal: BMC Cancer Date: 2009-10-06 Impact factor: 4.430

Heparin and cancer.

1. Six blind men and the elephant--the many faces of heparan sulfate.

2. In vivo treatment of rats with unfractionated heparin (UFH) or low molecular weight heparin (LMWH) does not affect experimentally induced colon carcinoma metastasis.

3. Heparin blocks transfer of extracellular vesicles between donor and recipient cells.

Review 4. Duration of anticoagulation for venous thromboembolism.

5. Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis.

Review 6. Treatment of cancer with anticoagulants: rationale in the treatment of melanoma.

Review 7. Impact of venous thromboembolism and anticoagulation on cancer and cancer survival.

8. Protease-activated receptors in cancer: A systematic review.

9. A catalytic role of heparin within the extracellular matrix.

10. FRAGMATIC: a randomised phase III clinical trial investigating the effect of fragmin added to standard therapy in patients with lung cancer.